124 related articles for article (PubMed ID: 1982761)
1. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
Simone P; Borgia M; Torre L; Ventresca GP
Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the bronchodilator effects of broxaterol and salbutamol.
Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
[TBL] [Abstract][Full Text] [Related]
4. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
7. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
[TBL] [Abstract][Full Text] [Related]
9. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Rampulla C; Corsico R; Majani U; Lodola E
Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
[TBL] [Abstract][Full Text] [Related]
10. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
11. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
[TBL] [Abstract][Full Text] [Related]
12. Asthma control during and after cessation of regular beta 2-agonist treatment.
Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE
Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
[TBL] [Abstract][Full Text] [Related]
13. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
Marlin GE; Turner P
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
[TBL] [Abstract][Full Text] [Related]
14. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
[TBL] [Abstract][Full Text] [Related]
15. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
16. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
17. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
18. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
19. Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
Giustina A; Malerba M; Bresciani E; Desenzani P; Licini M; Zaltieri G; Grassi V
J Endocrinol Invest; 1995 Dec; 18(11):847-52. PubMed ID: 8778156
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
